PECULIARITIES OF THE CONDITION OF FUNCTIONAL INSUFFICIENCY OF THE PANCREAS IN THE COMORBIDITY OF CHRONIC PANCREATITIS AND TYPE 2 DIABETES MELLITUS ON THE BACKGROUND OF PRIMARY OSTEOARTHRITIS
DOI:
https://doi.org/10.11603/1811-2471.2020.v.i4.11506Keywords:
primary osteoarthritis, chronic pancreatitis, type 2 diabetes mellitusAbstract
SUMMARY. Recent studies have shown a significant effect of pancreatic conditions on the course of comorbid pathology in patients with primary osteoarthritis.
The aim – to study the state of functional capacity of the pancreas in patients with comorbid chronic pancreatitis and type 2 diabetes mellitus on the background of primary osteoarthritis.
Material and Methods. 117 patients with CP on the background of primary OA with concomitant diabetes mellitus and without it were studied. The main group consisted of 92 outpatients with CP on the background of primary OA in combination with diabetes mellitus in the phase of stable or unstable remission, the comparison group – 25 patients with isolated CP on the background of primary OA, and the control group – 30 healthy individuals.
Results and Discussion. With the comorbidity of CP and diabetes mellitus on the background of primary OA, the excretory insufficiency of the pancreas was significantly more severe than in the group of patients with isolated CP, the content of fecal α-elastase – respectively (110.35±1.81) μg/g and (159.56±4.15) μg/g, which corresponded to the average and mild degrees of excretory insufficiency of the pancreas, respectively, and the score of the coprogram – respectively (5.60±0.10) and (3.89±0.16) points (p<0,05).
Conclusions. In the combined course of CP and diabetes mellitus on the background of OA, the correlation between fecal α-elastase-1 and glycosylated hemoglobin was statistically significantly stronger than in the group of patients with isolated CP, indicating a mutual burden of CP and diabetes mellitus.
References
Babinets, L.S., & Halabitska, I.M. (2020). Chronic inflammatory process and bone tissue changes in patients with osteoarthritis and exocrine pancreatic insufficiency. Lekarsky Obzor, 69 (1), 7-10.
Kothari, D., Ketwaroo, G., Freedman, S.D., & Sheth, S.G. (2017). The Impact of risk factors of chronic pancreatitis on secretin pancreatic function testing: results of a 20-year study. Pancreas, 46 (7), 887-890. DOI: 10.1097/MPA.0000000000000871.
Levy, P., Dominguez-Munoz, E., Imrie, C., Lohr, M., & Maisonneuve, P. (2014). Epidemiology of chronic pancreatitis: burden of the disease and consequences. United Eur. Gastroenterol. J., 2 (5), 345-54. DOI: 10.1177/2050640614548208.
Lew, D., Afghani, E., & Pandol, S. (2017). Chronic pancreatitis: current status and challenges for prevention and treatment. Dig. Dis. Sci., 62 (7), 1702-1712. DOI: 10.1007/sl0620- 017-4602-2.
Lohr, J.M., Oliver, M.R., & Frulloni, L. (2013). Synopsis of recent guidelines on pancreatic exocrine insufficiency. United Eur. Gastroenterol. J., l (2), 79-83. DOI: 10.1177/2050640613476500.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Achievements of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.